Fisher Wallace Laboratories, Inc.

Fisher Wallace Laboratories, Inc. is a medical device company based in Brooklyn, New York, founded in 2007. The company specializes in developing treatment options for conditions such as insomnia, anxiety, depression, and chronic pain through its innovative wearable brain stimulation technology. The flagship product, the Fisher Wallace Stimulator, utilizes cranial electrotherapy stimulation (CES) to help regulate brain activity, enhancing mental health and sleep quality. This scientifically validated device has been used by over 100,000 customers to manage stress and mood-related conditions. Fisher Wallace Laboratories is committed to clinical research and has invested significantly in trials, including studies during the COVID-19 pandemic, to support regulatory approval. The company collaborates with various institutions to enhance wellness programs and improve treatment outcomes. Led by co-founder and CEO Kelly Roman, the company focuses on providing effective solutions for individuals and organizations seeking wellness options. Fisher Wallace Laboratories is recognized for its commitment to quality, holding a BBB accreditation with an A+ rating.

• Employees 12
• Founded 2007
• Annual Revenue $4739000
• Total Funding $7399004